Skip to content

Journal article

Source notes

Frontiers in Psychiatry · 2017

Bibliographic details

Source record

Jennifer L. Temple, Christophe Bernard, Steven E. Lipshultz, Jason D. Czachor, Joslyn A. Westphal, Miriam A. Mestre

The Safety of Ingested Caffeine: A Comprehensive Review

Frontiers Media SA. 8. 80.

Study type
Comprehensive review
Review basis
Full text reviewed

Caffeine safety depends on who is consuming it, how much they take, and what else is involved. The authors bring together evidence on usual intake, adverse effects, and groups that may be more vulnerable. They describe up to 400 milligrams per day as a generally reassuring range for several health outcomes in healthy adults. This is not a daily target or a guarantee of no symptoms. Pregnancy, younger age, some health conditions, and medicine interactions change the context. The paper also highlights that caffeine can come from several foods, drinks, and medicines rather than one obvious source.

A population-level safety finding is not a personal threshold below which every effect disappears. Sleep disruption, anxiety, and other responses vary between individuals. Some evidence concerns coffee or energy drinks, which contain more than caffeine. Observed links between those products and health cannot always be assigned to caffeine alone. Severe events reported in individual cases also do not establish how often they occur among ordinary users.

How Does This Show Up in Real Life?

A practical question is whether you are evaluating one product or the day's combined exposure. A coffee, an energy drink, and a headache medicine may each appear to be separate decisions, yet the paper shows why their caffeine belongs in the same accounting. Product category is not enough: the amount and serving size matter. The authors support clearer labeling and attention to interactions with medicines. Their adult safety discussion should not be borrowed to judge a child's drink or caffeine use during pregnancy. Nor does staying under a quoted amount settle whether a product is interfering with your sleep. The useful application is to interpret an intake figure alongside the person and the circumstances, rather than treat it as an allowance that needs to be used.

The evidence varies in design, exposure measurement, and the products studied. Much of the information about uncommon harms comes from observational reports rather than controlled comparisons. Long-term evidence is less complete for vulnerable groups and newer consumption patterns. The authors identify a need for better monitoring of serious events and clearer information about combined exposures.

Why We Cite It

Alpekin gains a specific reason not to use natural origin as shorthand for safety. The paper includes plant-derived caffeine as well as added caffeine. Educational descriptions can identify the active substance and its amount without suggesting that a botanical source removes its effects or makes other ingredients in a product irrelevant.

This is useful evidence for setting the right questions around caffeine, not a certificate for every caffeinated product. Reassuring findings in healthy adults deserve their proper weight. They should neither erase an individual's adverse response nor be generalized to populations that were assessed differently.

Where this source appears

Pages citing this source

1 page · 1 article · 0 wikis

Articles